Profile
PBLA VRTX REGN SGEN ARGX ALNY
Company Name Panbela Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.17M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.01K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
PBLA VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
PBLA VRTX REGN SGEN ARGX ALNY
Last Close $0.315 $434.82 $560.93 $228.74 $622.93 $276.55
High 52 $1.11 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.24 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -71.62 % -15.85 % -53.32 % 0 % -7.27 % -6.81 %
Price vs. 52 Week Low 31.25 % 9.63 % 2.66 % 0 % 74.98 % 88.22 %
Total Return
PBLA VRTX REGN SGEN ARGX ALNY
1 Month Return 3.28 % -7.95 % 0.65 % 0 % 13.57 % 23.14 %
3 Month Return -10 % -7.35 % -20.94 % 0 % -3.67 % 0.13 %
6 Month Return -3.37 % -15.85 % -32.29 % 0 % 4.52 % -0.32 %
9 Month Return -30 % -6.68 % -49.62 % 0 % 18.6 % 2.25 %
YTD Return -14.86 % 7.98 % -21.25 % 0 % 1.29 % 17.53 %
1 Year Return -17.54 % 3.82 % -41.31 % 0 % 61.35 % 81.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PBLA VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
PBLA VRTX REGN SGEN ARGX ALNY
Asset Growth 137.08 % -0.87 % -1.21 %
Gross Profit Growth 28.22 % 10.25 % 22.93 %
Revenue Growth - 11.66 % 24.65 %
Revenue 3 Year - 45.6 % 91.56 %
Revenue 5 Year - 163.93 % 215.48 %
Revenue 10 Year -100 % 1632.15 % 494.04 %
EBIT Growth 25.88 % -93.69 % 10.13 %
Net Income Growth 27.68 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share -1470.67 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share -15191.94 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share -13055.09 % 33.84 % -624.16 %
Operating Income Growth -50.45 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) -65.29 % -113.93 % 9.07 %
Operating 3 Year CFG -1842.09 % -118.65 % -147.99 %
Operating 5 Year CFG -37708.48 % -131.3 % -195.86 %
Operating 10 Year CFG -78668.27 % 12.43 % -2622.09 %
EPS Growth -470.4 % -114.8 % 10.81 %
EPS Diluted Growth -470.4 % -114.97 % 10.81 %
Book Value Per Share -361.54 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -265.27 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share -62917.92 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -3671.11 % 1265.7 % 691.19 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -24.11 % 116.42 % -23.28 %
Free Cash Flow Growth -58.44 % -124.1 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2022
Profitability
PBLA VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM - 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -539.96 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM 304.71 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM 241.77 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 99.44 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 77.51 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM - -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -243.56 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM - 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 2.65 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM - 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM - 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -3.21 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -3.21 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 2.92 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -243.56 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -0.07 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -0.07 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -0.07 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
PBLA VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $-0.03B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.05B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.03B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -232429.55 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
PBLA VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $-0B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.01B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
PBLA VRTX REGN SGEN ARGX ALNY
Net Income $-0.03B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.16
ABCL AbCellera Biologics Inc. 2.005
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.48
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.02
ABSI Absci Corporation 2.79
ABUS Arbutus Biopharma Corporation 3.295
ABVC ABVC BioPharma, Inc. 1.31
ABVX Abivax SA American Depositary Shares 6.87
ACAD ACADIA Pharmaceuticals Inc. 16.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4785
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.44
ACIU AC Immune SA 1.645
ACLX Arcellx, Inc. 56.08
ETFs With Exposure to PBLA
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 177.365
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.11
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 132.12
VEMPX Vanguard Extended Market Index InstlPlus 0 326.02
Unlock